PD36-07 A HIGHER VOIDING SYMPTOM SUBSCORE AT BASELINE PREDICT POOR SATISFACTION OF ESCALATING MIRABGERON FROM 25 MG TO 50 MG FOR OVERACTIVE BLADDER PATIENTS | Zendy

AI Assistant Blog Pricing

PD36-07 A HIGHER VOIDING SYMPTOM SUBSCORE AT BASELINE PREDICT POOR SATISFACTION OF ESCALATING MIRABGERON FROM 25 MG TO 50 MG FOR OVERACTIVE BLADDER PATIENTS

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.